🇺🇸 FDA
Patent

US 9487780

Antisense compounds targeting genes associated with fibronectin

granted A61KA61K31/7105

Quick answer

US patent 9487780 (Antisense compounds targeting genes associated with fibronectin) held by Ionis Pharmaceuticals, Inc. expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7105